597 filings
Page 3 of 30
4
Stephen S. Yoder
28 Feb 23
PIERIS PHARMACEUTICALS / Stephen S. Yoder ownership change
5:09pm
4
Shane Olwill
28 Feb 23
PIERIS PHARMACEUTICALS / Shane Olwill ownership change
12:00am
SC 13G/A
Aquilo Capital Management, LLC
14 Feb 23
PIERIS PHARMACEUTICALS / Aquilo Capital Management ownership change
11:28am
SC 13G/A
Lynx1 Capital Management LP
14 Feb 23
PIERIS PHARMACEUTICALS / Lynx1 Capital Management ownership change
12:00am
SC 13G/A
Biotechnology Value Fund L P
14 Feb 23
PIERIS PHARMACEUTICALS / BIOTECHNOLOGY VALUE FUND L P ownership change
12:00am
SC 13G/A
PIRS
Pieris Pharmaceuticals Inc
10 Feb 23
PIERIS PHARMACEUTICALS / Seagen ownership change
4:20pm
SC 13G/A
PIRS
Pieris Pharmaceuticals Inc
10 Feb 23
PIERIS PHARMACEUTICALS / ASTRAZENECA ownership change
10:22am
SC 13G
Soleus Capital Master Fund, L.P.
27 Jan 23
PIERIS PHARMACEUTICALS / Soleus Capital Master Fund ownership change
5:02pm
SC 13G/A
Soleus Capital Master Fund, L.P.
26 Jan 23
PIERIS PHARMACEUTICALS / Soleus Capital Master Fund ownership change
5:01pm
8-K
PIRS
Pieris Pharmaceuticals Inc
10 Jan 23
Regulation FD Disclosure
4:31pm
CT ORDER
PIRS
Pieris Pharmaceuticals Inc
3 Jan 23
Confidential treatment order
12:00am
CT ORDER
PIRS
Pieris Pharmaceuticals Inc
3 Jan 23
Confidential treatment order
12:00am
CT ORDER
PIRS
Pieris Pharmaceuticals Inc
3 Jan 23
Confidential treatment order
12:00am
CT ORDER
PIRS
Pieris Pharmaceuticals Inc
16 Dec 22
Confidential treatment order
11:25am
424B5
PIRS
Pieris Pharmaceuticals Inc
4 Nov 22
Prospectus supplement for primary offering
5:10pm
8-K
PIRS
Pieris Pharmaceuticals Inc
4 Nov 22
Entry into a Material Definitive Agreement
4:30pm
10-Q
2022 Q3
PIRS
Pieris Pharmaceuticals Inc
Quarterly report
4 Nov 22
4:01pm
8-K
PIRS
Pieris Pharmaceuticals Inc
2 Nov 22
Pieris Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:43am
8-K
PIRS
Pieris Pharmaceuticals Inc
1 Nov 22
Pieris Pharmaceuticals Announces Dosing of First Subject In Phase 1 Trial of Inhaled CTGF Inhibitor PRS-220
9:20am
SC 13G
Lynx1 Capital Management LP
24 Oct 22
PIERIS PHARMACEUTICALS / Lynx1 Capital Management ownership change
4:57pm